Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $21.52 million. The enterprise value is $8.33 million.
| Market Cap | 21.52M |
| Enterprise Value | 8.33M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INDP has 8.54 million shares outstanding. The number of shares has increased by 1.68% in one year.
| Shares Outstanding | 8.54M |
| Shares Change (YoY) | +1.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 30.87% |
| Owned by Institutions (%) | 7.05% |
| Float | 5.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.05, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.05 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.80% and return on invested capital (ROIC) is -133.68%.
| Return on Equity (ROE) | -91.80% |
| Return on Assets (ROA) | -80.40% |
| Return on Capital (ROIC) | -133.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.20M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.13% in the last 52 weeks. The beta is 1.23, so INDP's price volatility has been higher than the market average.
| Beta (1Y) | 1.23 |
| 52-Week Price Change | -1.13% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 2.21 |
| Relative Strength Index (RSI) | 53.79 |
| Average Volume (30 Days) | 86,683 |
Short Selling Information
The latest short interest is 100,075, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 100,075 |
| Short Previous Month | 99,429 |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.70% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.38M |
| Pretax Income | -15.42M |
| Net Income | -15.42M |
| EBITDA | -15.42M |
| EBIT | -15.42M |
| Earnings Per Share (EPS) | -$1.83 |
Balance Sheet
The company has $13.36 million in cash and $175,053 in debt, giving a net cash position of $13.19 million or $1.54 per share.
| Cash & Cash Equivalents | 13.36M |
| Total Debt | 175,053 |
| Net Cash | 13.19M |
| Net Cash Per Share | $1.54 |
| Equity / Book Value | 12.08M |
| Book Value Per Share | 1.41 |
| Working Capital | 11.22M |
Cash Flow
| Operating Cash Flow | -13.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.41M |
| FCF Per Share | -$1.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.68% |
| Shareholder Yield | -1.68% |
| Earnings Yield | -71.68% |
| FCF Yield | -62.30% |
Analyst Forecast
The average price target for INDP is $12.00, which is 391.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 391.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 27, 2021. It was a reverse split with a ratio of 1:4.
| Last Split Date | Jul 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |